Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

5.3%

1 terminated/withdrawn out of 19 trials

Success Rate

94.4%

+7.9% vs industry average

Late-Stage Pipeline

21%

4 trials in Phase 3/4

Results Transparency

35%

6 of 17 completed trials have results

Key Signals

6 with results

Enrollment Performance

Analytics

Phase 3

4(44.4%)

Phase 1

3(33.3%)

N/A

1(11.1%)

Phase 2

1(11.1%)

9Total

Phase 3(4)

Phase 1(3)

N/A(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials

NCT02814825Completed

An ACDF Multi-Center Study Using ViviGen Cellular Bone Matrix

Role: lead

NCT01661998Completed

Prospective Study of Motion Preservation Evaluation Below Fusions of the Spine in Adolescent Idiopathic Scoliosis

Role: collaborator

NCT01661959Unknown

Adolescent Idiopathic Scoliosis Outcomes Database Registry

Role: collaborator

NCT01588054Completed

Prospective Radiographic and Clinical Evaluation of Surgical Treatment for Cervical Deformity

Role: collaborator

NCT00432159Not ApplicableCompleted

Comparison of DISCOVER™ Artificial Cervical Disc and ACDF for Treatment of Cervical DDD (IDE Study)

Role: lead

NCT01880164Completed

Cost Effectiveness of Nonoperative Management for Adult Spinal Deformity

Role: collaborator

NCT00738309Completed

Prospective Study of Scheuermann's Kyphosis

Role: collaborator

NCT00813813Phase 1Completed

Intradiscal rhGDF-5 Phase I/II Clinical Trial

Role: lead

NCT01182337Phase 1Completed

A Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration

Role: lead

NCT01158924Phase 1Completed

A Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration

Role: lead

NCT01124006Phase 2Completed

A Multicenter, Randomized, Double-blind, Placebo Controlled, Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of 2 Doses of Intradiscal rhGDF-5 (Single Administration) for the Treatment of Early Stage Lumbar Disc Degeneration

Role: lead

NCT00215332Completed

CHARITE™ vs. ALIF 5-Year Follow-up

Role: lead

NCT00215306Phase 3Completed

CHARITÉ™ Artificial Disc Compared to Anterior Interbody Fusion for Treatment of Degenerative Disc Disease

Role: lead

NCT00215293Phase 3Completed

Cervical I/F Cage for Anterior Cervical Fusion

Role: lead

NCT00215319Phase 3Completed

Titanium Surgical Mesh and MOSS-Miami Screws for Lumbar Fusion.